<?xml version="1.0" encoding="UTF-8"?>
<ref id="B58">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Eliasson</surname>
    <given-names>D. G.</given-names>
   </name>
   <name>
    <surname>El Bakkouri</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Schon</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Ramne</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Festjens</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Lowenadler</surname>
    <given-names>B.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2008</year>). 
  <article-title>CTA1-M2e-DD: a novel mucosal adjuvant targeted influenza vaccine</article-title>. 
  <source>Vaccine</source>
  <volume>26</volume>, 
  <fpage>1243</fpage>â€“
  <lpage>1252</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2007.12.027</pub-id>
  <?supplied-pmid 18243429?>
  <pub-id pub-id-type="pmid">18243429</pub-id>
 </mixed-citation>
</ref>
